Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

04 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251104528525/en/Meitheal-Pharmaceuticals-Receives-Approval-from-the-US-Food-and-Drug-Administration-for-CONTEPO-fosfomycin-for-injection-in-Patients-18-Years-Having-Complicated-Urinary-Tract-Infections-cUTI-Including-Acute-Pyelonephritis-AP

22 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212271

20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251020126688/en/Meitheal-Pharmaceuticals-to-Present-New-Data-in-Infectious-Disease-Portfolio-at-IDWeek-2025

31 Jul 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/meitheal-pharmaceuticals-expands-medical-affairs-operations-with-two-appointments/

31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731498961/en/Meitheal-Pharmaceuticals-Announces-Appointment-of-Dr.-Keith-Robinson-as-Chief-Medical-Officer-and-Expansion-of-Medical-Affairs-Operation

29 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250529061176/en/Meitheal-Pharmaceuticals-Announces-Launch-of-Generic-Paclitaxel-Formulation-in-the-United-States-Through-Exclusive-Commercial-Licensing-Agreement
ABOUT THIS PAGE